Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Sato Website

Noriko Sato, M.D., Ph.D.

Selected Publications

1)  Harada T, Sano K, Sato K, Watanabe R, Yu Z, Hanaoka H, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H.
Activatable organic near-infrared fluorescent probes based on a bacteriochlorin platform: synthesis and multicolor in vivo imaging with a single excitation.
Bioconjug. Chem. 25: 362-9, 2014.
[Journal]
2)  Ali T, Nakajima T, Sano K, Sato K, Choyke PL, Kobayashi H.
Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.
Contrast Media Mol Imaging. 9: 276-82, 2014.
[Journal]
3)  Nakajima T, Sano K, Sato K, Watanabe R, Harada T, Hanaoka H, Choyke PL, Kobayashi H.
Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites.
Cancer Sci. 105: 308-14, 2014.
[Journal]
4)  Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H.
Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Mol Oncol. [Epub ahead of print], 2014.
[Journal]
5)  Nakajima T, Turkbey B, Sano K, Sato K, Bernardo M, Hoyt RF, Choyke PL, Kobayashi H.
MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.
J Magn Reson Imaging. 2013.
[Journal]
6)  Ju W, Zhang M, Jiang JK, Thomas CJ, Oh U, Bryant BR, Chen J, Sato N, Tagaya Y, Morris JC, Janik JE, Jacobson S, Waldmann TA.
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Blood. 117: 1938-46, 2011.
[Journal]
7)  Sato N, Sabzevari H, Fu S, Ju W, Petrus MN, Bamford RN, Waldmann TA, Tagaya Y.
Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Ra.
Blood. 117: 4032-40, 2011.
[Journal]
8)  Shin IS, Lee S, Kim HS, Yao Z, Regino C, Sato N, Cheng KT, Hassan R, Campo MF, Albone EF, Choyke PL, Pastan I, Paik CH.
Effect of chelator conjugation level and injection dose on tumor and organ uptake of (111)In-labeled MORAb-009, an anti-mesothelin antibody.
Nucl Med Biol. [Epub ahead of print], 2011.
[Journal]
9)  Yokoyama S, Watanabe N, Sato N, Perera PY, Filkoski L, Tanaka T, Miyasaka M, Waldmann TA, Hiroi T, Perera LP.
Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes.
Proc. Natl. Acad. Sci. U.S.A. 106: 15849-54, 2009.
[Journal]
10)  Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H.
In vivo real-time, multicolor, quantum dot lymphatic imaging.
J. Invest. Dermatol. 129: 2818-22, 2009.
[Journal]
11)  Sato N, Patel HJ, Waldmann TA, Tagaya Y.
The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells.
Proc. Natl. Acad. Sci. U.S.A. 104: 588-93, 2007.
[Journal]
12)  Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Hinrichs CS, Heinrichs C, Klebanoff CA, Tagaya Y, Restifo NP.
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
J. Immunol. 176: 5255-66, 2006.
[Journal]
13)  Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL.
Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle.
Neoplasia. 7: 984-91, 2005.
[Journal]
14)  Sato N, Hassan R, Axworthy DB, Wong KJ, Yu S, Theodore LJ, Lin Y, Park L, Brechbiel MW, Pastan I, Paik CH, Carrasquillo JA.
Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
J. Nucl. Med. 46: 1201-9, 2005.
[Journal]
15)  Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, Waldmann TA, Tagaya Y.
Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance.
Blood. 105: 721-7, 2005.
[Journal]
16)  Mamede M, Saga T, Ishimori T, Higashi T, Sato N, Kobayashi H, Brechbiel MW, Konishi J.
Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex.
J Control Release. 95: 133-41, 2004.
[Journal]
17)  Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA.
Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.
J. Natl. Cancer Inst. 96: 703-8, 2004.
[Journal]
18)  Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW.
Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
Magn Reson Med. 50: 758-66, 2003.
[Journal]
19)  Mamede M, Saga T, Ishimori T, Nakamoto Y, Sato N, Higashi T, Mukai T, Kobayashi H, Konishi J.
Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.
Neoplasia. 5: 179-83, 2003.
[Journal]
20)  Nakamoto Y, Saga T, Higashi T, Ishimori T, Kobayashi H, Ishizu K, Sato N, Mamede M, Sakahara H, Imamura M, Konishi J.
Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose.
Ann Nucl Med. 17: 421-6, 2003.
[Journal]
21)  Mamede M, Saga T, Kobayashi H, Ishimori T, Higashi T, Sato N, Brechbiel MW, Konishi J.
Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors.
Clin. Cancer Res. 9: 3756-62, 2003.
[Journal]
22)  Sato N, Park CW, Kim HS, Han ES, Wong KJ, Paik RS, Park LS, Yao Z, Carrasquillo JA, Paik CH.
Synthesis of dendrimer-based biotin radiopharmaceuticals to enhance whole-body clearance.
Nucl. Med. Biol. 30: 617-25, 2003.
[Journal]
23)  Kobayashi H, Saga T, Kawamoto S, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW.
Dynamic micro-MRI of liver micrometastasis with a novel liver macromolecular MR contrast agent DAB-Am64-(1B4M-Gd)64.
Acad Radiol. 9 Suppl 2: S452-4, 2002.
[Journal]
24)  Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, Sato N, Konishi J.
Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation.
J. Nucl. Med. 43: 658-63, 2002.
[Journal]
25)  Kobayashi H, Shirakawa K, Kawamoto S, Saga T, Sato N, Hiraga A, Watanabe I, Heike Y, Togashi K, Konishi J, Brechbiel MW, Wakasugi H.
Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256).
Cancer Res. 62: 860-6, 2002.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/11/2014.